SH2D2A and plasma cell myeloma: SH2D2A was upregulated in T cells that infiltrated ovarian and renal cancers and multiple myeloma, but was downregulated in T cells infiltrating breast cancers (Table 2), supporting an inverse mechanistic role for SH2D2A dependent on tumor type.